Journal rankings · indicator year 2012
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2012
Genetics journal rankings 2012
14 ranked journals · Subfield in Medicine
Genetics has 14 ranked journals in 2012. The median OJR fell 0.08 on 2011 to 0.63, below the world average of 1.00; Q1 starts at OJR 1.38. The top three are Neuro-Oncology, Brain Pathology, and Current Stem Cell Research & Therapy.
Ranks and citation indicators: 2012. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2009–2011, the window the 2012 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery610
- Pulmonary and Respiratory Medicine245
- Public Health, Environmental and Occupational Health213
- Cardiology and Cardiovascular Medicine209
- Oncology153
- Epidemiology147
- Infectious Diseases144
- Endocrinology, Diabetes and Metabolism124
- Neurology120
- Radiology, Nuclear Medicine and Imaging112
- Physiology110
- Psychiatry and Mental health109
- Genetics14
Show all 42 subfields
- Orthopedics and Sports Medicine85
- Ophthalmology67
- Pediatrics, Perinatology and Child Health67
- Dermatology64
- Hematology60
- Obstetrics and Gynecology55
- Rheumatology53
- Nephrology40
- Pharmacology38
- Complementary and alternative medicine37
- Reproductive Medicine37
- Geriatrics and Gerontology34
- Emergency Medicine32
- Otorhinolaryngology28
- Rehabilitation21
- Critical Care and Intensive Care Medicine20
- Pathology and Forensic Medicine20
- Hepatology16
- Immunology and Allergy13
- Anesthesiology and Pain Medicine10
- Urology10
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
14 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2011. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2009–2011, the window the 2012 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2009–2011 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2003 to 2012. | Compare |
|---|---|---|---|---|---|---|---|
1Neuro-OncologyOxford University Press · United States | 2.53Q1 | 6.88 0.18 down from 2011 | 342 | 90% | $5,132 | ||
2Brain PathologyOAWiley · United Kingdom | 1.89Q1 | 4.09 0.54 down from 2011 | 277 | 94% | $4,080 | ||
3Current Stem Cell Research & TherapyBentham Science Publishers · Netherlands | 1.51Q1 | 3.96 0.13 up from 2011 | 115 | 6% | — | ||
4Journal of Neuro-OncologySpringer Science+Business Media · Netherlands | 1.38Q1 | 3.50 0.34 up from 2011 | 967 | 26% | $4,590 | ||
5Advances in HematologyOAHindawi Publishing Corporation · United Kingdom | 0.98Q2 | 2.74 0.99 up from 2011 | 105 | 100% | $860 | ||
6Blood Cells Molecules and DiseasesElsevier BV · United States | 0.91Q2 | 2.45 0.11 up from 2011 | 320 | 19% | $4,030 | ||
7Brain Tumor PathologySpringer Science+Business Media · Japan | 0.78Q2 | 2.00 0.46 up from 2011 | 106 | 18% | $4,290 | ||
8Pediatric NeurosurgeryKarger Publishers · Switzerland | 0.47Q3 | 0.79 0.12 down from 2011 | 266 | 6% | — | ||
9Clinical NeuropathologyDustri-Verlag · Germany | 0.43Q3 | 0.94 0.39 down from 2011 | 181 | 12% | — | ||
10HemoglobinTaylor & Francis · United States | 0.37Q3 | 1.16 0.30 down from 2011 | 270 | 5% | — | ||
11Stem Cells and Cloning Advances and ApplicationsOADove Medical Press · New Zealand | 0.24Q3 | 0.43 0.48 down from 2011 | 30 | 100% | $2,320 | ||
12International Journal of Cancer ResearchOAPakistan | 0.18Q4 | 0.27 0.60 down from 2011 | 122 | 42% | — | ||
13Annales de biologie cliniqueJohn Libbey Eurotext · France | 0.17Q4 | 0.32 0.06 up from 2011 | 379 | 1% | — | ||
14Thalassemia ReportsOAPAGEPress (Italy) · Switzerland | 0.06Q4 | 0.13no 2011 value | 30 | 100% | $1,207 | — |
Subfields of Medicine, with Genetics highlighted.
- Surgery610
- Pulmonary and Respiratory Medicine245
- Public Health, Environmental and Occupational Health213
- Cardiology and Cardiovascular Medicine209
- Oncology153
- Epidemiology147
- Infectious Diseases144
- Endocrinology, Diabetes and Metabolism124
- Neurology120
- Radiology, Nuclear Medicine and Imaging112
- Physiology110
- Psychiatry and Mental health109
- Orthopedics and Sports Medicine85
- Ophthalmology67
- Pediatrics, Perinatology and Child Health67
- Dermatology64
- Hematology60
- Obstetrics and Gynecology55
- Rheumatology53
- Nephrology40
- Pharmacology38
- Complementary and alternative medicine37
- Reproductive Medicine37
- Geriatrics and Gerontology34
- Emergency Medicine32
- Otorhinolaryngology28
- Rehabilitation21
- Critical Care and Intensive Care Medicine20
- Pathology and Forensic Medicine20
- Hepatology16
- Genetics14
- Immunology and Allergy13
- Anesthesiology and Pain Medicine10
- Urology10
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2012. Corpus-wide, 75.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
12 additional Genetics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2009–2011, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2012. Publication window: 2009–2011. How these summaries are calculated
- Ranked journals
- 14
- Window papers (baseline)
- 25,125 +30.1% from indicator year 2009
- Median OJR
- 0.63 -17.1% from indicator year 2009
- Rising journals (2025)
- 1
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2009–2011 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 11 | 11 | 11 | 12 | 14 | 17 | 19 | 19 | 20 | 21 | 20 | 24 | 22 | 20 | 20 | 22 | 19 | 19 | |
| Window papers (baseline) | 8,174 | 8,914 | 9,291 | 9,951 | 10,618 | 11,882 | 13,437 | 15,225 | 16,957 | 19,312 | 22,101 | 24,018 | 25,125 | 25,315 | 27,083 | 28,642 | 30,424 | 31,370 | 32,560 | 33,624 | 35,248 | 37,122 | 39,044 | 39,485 | 39,131 | 39,396 | |
| Median OJR | 0.44 | 0.50 | 0.553 | 0.623 | 0.73 | 0.79 | 0.540 | 0.39 | 0.45 | 0.76 | 0.74 | 0.707 | 0.63 | 0.37 | 0.33 | 0.526 | 0.555 | 0.619 | 0.710 | 0.47 | 0.678 | 0.67 | 0.60 | 0.537 | 0.531 | 0.680 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.